Crook T B, Ardolino A, Williams L A P, Barlow I W
Poole General Hospital, Dorset, UK.
Ann R Coll Surg Engl. 2009 Jul;91(5):361-5. doi: 10.1308/003588409X428559. Epub 2009 Apr 30.
Patients who have previously undergone meniscectomy are known to potentially suffer subsequent knee problems including degenerative changes. Meniscal transplantation has been proposed as a possible solution to these problems. This article aims to review the current literature to consolidate the evidence surrounding the use of human meniscal allograft transplantation.
Three databases (PubMed, Embase and Medline) were searched to find English language articles pertaining to meniscal allograft transplantation. Each article was critiqued by two authors using a structured appraisal tool, and stratified according to the level of evidence.
No Level I or II studies were identified. Many studies had small study groups with limited follow-up and patient selection and description of patient factors varied greatly. This made comparing data difficult. There were also very few papers concentrating on isolated meniscal transplantation. Four types of graft are used--fresh, fresh-frozen, cryopreserved and freeze-dried (lyophilised) graft. Cryopreserved and fresh-frozen allografts are deemed most suitable. Most authors advocate the use of non-irradiated grafts from screened donors to reduce transmission of infection. Best results occur when using bony anchors to fix the graft, although this requires accurate graft positioning. Patients have an improved outcome if they have less severe degenerative changes within the knee prior to transplantation.
No statistically significant studies looking at isolated meniscal transplantations have been found. The evidence suggests that meniscal allograft transplantation provides improvement of pain and function in the short and intermediate term. The effect on future joint degeneration is still unknown. The ideal patient group includes patients less than 40 years of age with knee pain, proven meniscal injury and a normally aligned, stable joint without severe degenerative changes.
已知先前接受过半月板切除术的患者可能会出现包括退行性改变在内的后续膝关节问题。半月板移植已被提议作为解决这些问题的一种可能方法。本文旨在回顾当前文献,以巩固围绕使用人半月板同种异体移植的证据。
检索了三个数据库(PubMed、Embase和Medline),以查找与半月板同种异体移植相关的英文文章。每篇文章由两位作者使用结构化评估工具进行评判,并根据证据水平进行分层。
未发现一级或二级研究。许多研究的样本量小,随访有限,患者选择以及患者因素的描述差异很大。这使得数据比较困难。专注于单纯半月板移植的论文也非常少。使用的移植物有四种类型——新鲜的、新鲜冷冻的、深低温保存的和冻干(冻干)的移植物。深低温保存的和新鲜冷冻的同种异体移植物被认为是最合适的。大多数作者主张使用来自经过筛选的供体的未辐照移植物,以减少感染传播。使用骨锚固定移植物时效果最佳,尽管这需要精确的移植物定位。如果患者在移植前膝关节内的退行性改变较轻,则预后会更好。
尚未发现关于单纯半月板移植的具有统计学意义的研究。证据表明,半月板同种异体移植在短期和中期可改善疼痛和功能。对未来关节退变的影响仍不清楚。理想的患者群体包括年龄小于40岁、有膝关节疼痛、经证实有半月板损伤且关节对线正常、稳定且无严重退行性改变的患者。